Picture of Berkley Renewables logo

BKS Berkley Renewables Share Price

0.000.00%
ca flag iconLast trade - 00:00
UtilitiesMicro Cap

Momentum

Relative Strength (%)
1m+10.82%
3m+9.25%
6m+140.18%
1yr-60.57%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-54.98%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201831st Dec 2019
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2018 / 2019

Blurred out image of Berkley Renewables EPS forecast chart

Profile Summary

Berkley Renewables Inc. is a Canada-based growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. (RepliCel). RepliCel's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. RepliCel is also developing an injection device (RCI) for optimal clinical delivery. It is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.

Directors

Last Annual
December 31st, 2017
Last Interim
September 30th, 2018
Incorporated
July 18th, 1986
Public Since
May 22nd, 1981
No. of Employees
7
Sector
Electric Utilities & IPPs
Industry
Utilities
Exchange
ca flag iconCanadian Securities Exchange
Shares in Issue
10,411,451

BKS Share Price Performance

Similar to BKS

Picture of Gencan Capital logo

Gencan Capital

ca flag iconCanadian Securities Exchange

Picture of Reservoir Capital logo

Reservoir Capital

ca flag iconCanadian Securities Exchange

FAQ